ADIM
MANH icon

Alpha DNA Investment Management’s Manhattan Associates MANH Stock Holding History

Alpha DNA Investment Management’s Portfolio MANH Stock Details MANH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,298
Closed -$621K – 98
2024
Q4 		$621K Sell
2,298
-869
-27% -$248K 0.24% 90
2024
Q3 		$891K Buy
3,167
+382
+14% +$97.2K 0.33% 61
2024
Q2 		$687K Sell
2,785
-2,574
-48% -$584K 0.27% 79
2024
Q1 		$1.34M Buy
5,359
+1,211
+29% +$288K 0.5% 38
2023
Q4 		$893K Buy
4,148
+2,967
+251% +$628K 0.35% 54
2023
Q3 		$233K Buy
+1,181
New +$230K 0.1% 155

Other funds holding MANH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's MANH Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Manhattan Associates (MANH) in Q1 2025, closing a stake of 2,298 shares — an estimated $621K sold.

Alpha DNA Investment Management first reported a position in MANH in Q3 2023 and held it in 6 quarters. The position peaked at $1.34M in Q1 2024. 610 funds tracked by Wall St. Rank hold MANH as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Manhattan Associates position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,298 Manhattan Associates shares in Q1 2025, an estimated $621K.
  • Alpha DNA Investment Management first reported a position in Manhattan Associates in Q3 2023 and held it in 6 quarters.
  • Alpha DNA Investment Management's Manhattan Associates position peaked at $1.34M in Q1 2024.
  • 610 funds tracked by Wall St. Rank held Manhattan Associates as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.